Bristol-Myers Squibb confirms it’s a target of bribery probe

Bristol-Myers Squibb ($BMY) has made it official. It is under federal investigation, potentially for foreign bribery. In a filing Thursday, it just said that the SEC has started a probe of its sales a…
Read the full story: News